RebeccaAnnPrevisMD

PubMed

• Health Care Access Dimensions and Racial Disparities in End-of-Life Care Quality among Patients with Ovarian Cancer.
  Shama Karanth, Oyomoare L Osazuwa-Peters, Lauren E Wilson, Fariha Rahman, Bin Huang, Maria Pisu, Kevin C Ward, Maria J Schymura, Tomi F Akinyemiju, Rebecca A Previs, M...> ;Cancer Research Communications. 2024 Mar 18
• Efficacy of cyclin-dependent kinase 4/6 inhibitors in combination with hormonal therapy in patients with recurrent granulosa cell tumor of the ovary: A case series.
  Benjamin B Albright, Stephanie Shuey, Angeles Alvarez Secord, Laura J Havrilesky, Andrew Berchuck, Rebecca A Previs> ;Gynecologic Oncology Reports. 2023 Dec 1
• Recent Advances in Gynecological Malignancies: Focus on ASCO 2023.
  Olga Bodriagova, Rebecca Ann Previs, Lydia Gaba, Abhishek Shankar, Laura Vidal, Kamal S Saini> ;Oncology and Therapy. 2023 Dec 1
• 2 citations
  Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis.
  Debarati Mukherjee, Rebecca A Previs, Corinne Haines, Muthana Al Abo, Patrick K Juras, Kyle C Strickland, Binita Chakraborty, Sandeep Artham, Regina S Whitaker, Kather...> ;Cancer Research. 2023 Sep 1
• 2 citations
  RNA Sequencing Identifies Novel NRG1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers.
  Eric Severson, Bhagelu R Achyut, Mary Nesline, Sarabjot Pabla, Rebecca A Previs, Geoffrey Kannan, Anjen Chenn, Shengle Zhang, Roger Klein, Jeffrey Conroy, Mark Sausen,...> ;The Journal of Molecular Diagnostics. 2023 Jul 1
• 1 citations
  An obstetrician-gynecologist's review of hernias: risk factors, diagnosis, prevention, and repair.
  Stephanie L Lim, David A Brown, Grant Darner, Howard Levinson, Laura J Havrilesky, Rebecca A Previs, Knochenhauer, H.> ;American Journal of Obstetrics and Gynecology. 2023 Sep 1
• 4 citations
  Health-care access dimensions and ovarian cancer survival: SEER-Medicare analysis of the ORCHiD study.
  Mary Katherine Montes de Oca, Quan Chen, Elizabeth Howell, Lauren E Wilson, Clare Meernik, Rebecca A Previs, Bin Huang, Maria Pisu, Margaret I Liang, Kevin C Ward, Mar...> ;JNCI Cancer Spectrum. 2023 Mar 1
• 2 citations
  Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist Consultation.
  Anjali Gupta, Quan Chen, Lauren E Wilson, Bin Huang, Maria Pisu, Margaret Liang, Rebecca A Previs, Haley A Moss, Kevin C Ward, Maria J Schymura, Andrew Berchuck, Tomi ...> ;JAMA Network Open. 2023 Feb 1
• 2 citations
  Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis.
  Benjamin B Albright, Tressa Ellett, Emily C Goins, Karen A Monuszko, Samantha J Kaplan, Rebecca A Previs, Haley A Moss, Laura J Havrilesky, Brittany A Davidson, Hope E...> ;BJOG. 2023 Apr 1
• Association of Genomic Instability Score, Tumor Mutational Burden, and Tumor-Infiltrating Lymphocytes as Biomarkers in Uterine Serous Carcinoma.
  Elizabeth A Bloom, Pamela N Peters, Regina Whitaker, Shonagh Russell, Benjamin Albright, Shelly Cummings, Kirsten M Timms, Thomas Slavin, Braden Probst, Kyle C Strickl...> ;Cancers. 2023 Jan 15
• 2 citations
  Healthcare Access Domains Mediate Racial Disparities in Ovarian Cancer Treatment Quality in a US Patient Cohort: A Structural Equation Modelling Analysis.
  Tomi Akinyemiju, Quan Chen, Lauren E Wilson, Rebecca A Previs, Ashwini Joshi, Margaret Liang, Maria Pisu, Kevin C Ward, Andrew Berchuck, Maria J Schymura, Bin Huang> ;Cancer Epidemiology, Biomarkers & Prevention. 2023 Jan 9
• Healthcare access dimensions and uterine cancer survival: a national cancer database study.
  Mary Katherine Anastasio, Anjali Gupta, Tomi F Akinyemiju, Rebecca A Previs> ;Frontiers in Oncology. 2023 Jan 1
• 1 citations
  Stress hormones are associated with inflammatory cytokines and attenuation of T-cell function in the ascites from patients with high grade serous ovarian cancer.
  Alexandra N Aquino-Acevedo, Hope Knochenhauer, Yesenia Castillo-Ocampo, Melanie Ortiz-León, Yadiel A Rivera-López, Camily Morales-López, Melanie E Cruz-Robles, Elvin R...> ;Brain, Behavior, & Immunity - Health. 2022 Dec 1
• 3 citations
  Telemedicine and gynecologic oncology: caring for patients remotely during a global pandemic.
  Janice Wong, Rafael Gonzalez, Benjamin Albright, Taylor Hayes, Anthony Swartz, Laura J Havrilesky, Paula S Lee, Rebecca A Previs> ;AJOG Global Reports. 2022 Nov 1
• 10 citations
  Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study.
  Mary Katherine Montes de Oca, Lauren E Wilson, Rebecca A Previs, Anjali Gupta, Ashwini Joshi, Bin Huang, Maria Pisu, Margaret Liang, Kevin C Ward, Maria J Schymura, An...> ;Journal of the National Comprehensive Cancer Network. 2022 Nov 1
• 6 citations
  Diversity and transparency in gynecologic oncology clinical trials.
  Mary Katherine Montes de Oca, Elizabeth P Howell, Daniel Spinosa, Benjamin J Peipert, Eric Severson, Shakti Ramkissoon, Tomi F Akinyemiju, Rebecca A Previs, Knochenhau...> ;Cancer Causes & Control. 2023 Feb 1
• 1 citations
  Using genetically encoded fluorescent biosensors to interrogate ovarian cancer metabolism.
  Shree Bose, Haipei Yao, Qiang Huang, Regina Whitaker, Christopher D Kontos, Rebecca A Previs, Xiling Shen> ;Journal of Ovarian Research. 2022 Oct 20
• 2 citations
  Race, Affordability and Utilization of Supportive Care in Ovarian Cancer Patients.
  Mercy C Anyanwu, Onyinye Ohamadike, Lauren E Wilson, Clare Meernik, Bin Huang, Maria Pisu, Margaret Liang, Rebecca A Previs, Ashwini Joshi, Kevin C Ward, Tom Tucker, M...> ;Journal of Pain and Symptom Management. 2022 Dec 1
• Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer.
  Shonagh Russell, Felicia Lim, Pamela N Peters, Suzanne E Wardell, Regina Whitaker, Ching-Yi Chang, Rebecca A Previs, Donald P McDonnell> ;Cancers. 2022 Aug 30
• 1 citations
  Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor Board.
  Michelle F Green, Catherine H Watson, Sarah Tait, Jie He, Dean C Pavlick, Garrett Frampton, Jinny Riedel, Jennifer K Plichta, Andrew J Armstrong, Rebecca A Previs, Noa...> ;The Oncologist. 2023 Jan 18
• Ridiculously good writing: How to write like a pro and publish like a boss.
  Susan C Modesitt, Laura J Havrilesky, Rebecca A Previs, J Alejandro Rauh-Hain, J Michael Straughn, Jamie N Bakkum-Gamez, Katherine C Fuh, David E Cohn> ;Gynecologic Oncology Reports. 2022 Aug 1
• Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian Cancer.
  Tomi F Akinyemiju, Lauren E Wilson, Nicole Diaz, Anjali Gupta, Bin Huang, Maria Pisu, April Deveaux, Margaret Liang, Rebecca A Previs, Haley A Moss, Ashwini Joshi, Kev...> ;Cancer Epidemiology, Biomarkers & Prevention. 2022 Jul 1
• 10 citations
  G6PD inhibition sensitizes ovarian cancer cells to oxidative stress in the metastatic omental microenvironment.
  Shree Bose, Qiang Huang, Yunhan Ma, Lihua Wang, Grecia O Rivera, Yunxin Ouyang, Regina Whitaker, Rebecca A Gibson, Christopher D Kontos, Andrew Berchuck, Rebecca A Pre...> ;Cell Reports. 2022 Jun 28
• 8 citations
  Malnutrition as a risk factor for post-operative morbidity in gynecologic cancer: Analysis using a national surgical outcomes database.
  Emily C Goins, Jeremy M Weber, Tracy Truong, Haley A Moss, Rebecca A Previs, Brittany A Davidson, Laura J Havrilesky> ;Gynecologic Oncology. 2022 May 1
• 11 citations
  Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
  Allan B. Huang, Jenny Wu, Ling Chen, Benjamin B. Albright, Rebecca A. Previs, Haley A. Moss, Brittany A. Davidson, Laura J. Havrilesky, Alexander Melamed, Jason D. Wright> ;Gynecologic Oncology Reports. 2021 Nov 1
• Join now to see all

Journal Articles

• Differential Expression of Immune Related Genes in High-Grade Ovarian Serous Carcinoma  
  Rebecca A Previs, Angeles Alvarez Secord, Gynecologic Oncology

Lectures

• Bevacizumab beyond progression: Impact of subsequent bevacizumab retreatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression. 
  2019 ASCO Annual Meeting - 6/1/2019